Target intelligence / Profile preview

Influenza hemagglutinin stalk region (HA stalk)

Target
HA stalk
Molecular classification
Viral glycoprotein, Class I fusion protein, Surface antigen
01

Overview

The Influenza hemagglutinin stalk region is a highly conserved structural component of the hemagglutinin (HA) glycoprotein, the primary surface antigen of the influenza virus. While the HA head domain undergoes frequent antigenic drift to evade the immune system, the stalk region—comprising the HA2 subunit and portions of HA1—remains relatively invariant across diverse influenza subtypes (Corti & Lanzavecchia, 2013). This high level of conservation makes the stalk a premier target for the development of universal influenza vaccines and broadly neutralizing antibodies (bnAbs) intended to provide protection against seasonal and pandemic strains (Krammer & Palese, 2013). Biologically, the stalk region mediates the critical step of membrane fusion between the viral envelope and the host cell endosome, a process triggered by the acidic environment of the endocytic pathway (Impagliazzo et al., 2015). Therapeutic agents, including monoclonal antibodies like MEDI8852 and small molecules like JNJ-4796, function by binding to this region and stabilizing the pre-fusion state of the protein (van Dongen et al., 2019). By physically blocking the conformational rearrangements necessary for fusion, these inhibitors prevent the release of the viral genome into the host cell, effectively neutralizing the virus across multiple lineages.

Other names
Hemagglutinin stem domainHA stemHA2 subunitConserved stalk regionHemagglutinin fusion domain
02

Mechanism of action

Binding to the conserved stalk region prevents the pH-triggered conformational change of hemagglutinin, thereby inhibiting the fusion of the viral envelope with the host endosomal membrane and blocking viral genome release into the cytoplasm.

03

Biological functions

Membrane fusionViral entryEndosomal escapeConformational rearrangement
04

Disease associations

InfectionInfluenza AInfluenza BPandemic influenza
05

Safety considerations

Antibody-dependent enhancement (ADE)Low immunogenicity compared to the immunodominant head domainPotential for rare viral escape mutations in the conserved pocketOff-target effects of scaffold proteins in chimeric vaccine designs
06

Interacting drugs

CR6261

7 more in the full profile.

07

Biomarkers

Anti-HA stalk antibody titers (ELISA)HA-stalk specific memory B cellsStalk-reactive IgG levels

Beyond the preview

Go deeper on Influenza hemagglutinin stalk region (HA stalk).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza hemagglutinin stalk region (HA stalk).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call